VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | The use of radiomics and artificial intelligence for sickle cell disease

Raffaella Colombatti, MD, PhD, University of Padova, Padova, Italy, shares some insights into the use of radiomics and artificial intelligence for sickle cell disease (SCD) and the GENOMED4ALL European project. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter